Biblio

Found 5 results

Filters: Author is LaVigne, Justin [Clear All Filters]

2020

LaVigne J, Keresztes A, Chiem D, Streicher JM. 2020. The endomorphin-1/2 and dynorphin-B peptides display biased agonism at the mu opioid receptor.. Pharmacol Rep. 72(2):465-471.

2017

Xie JY, De Felice M, Kopruszinski CM, Eyde N, LaVigne J, Remeniuk B, Hernandez P, Yue X, Goshima N, Ossipov M et al.. 2017. Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention.. Cephalalgia. 37(8):780-794.

Olson KM, Lei W, Keresztes A, LaVigne J, Streicher JM. 2017. Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain.. Yale J Biol Med. 90(1):97-110.

2016

Ramos-Colon CN, Lee YSun, Remesic M, Hall SM, LaVigne J, Davis P, Sandweiss AJ, McIntosh MI, Hanson J, Largent-Milnes TM et al.. 2016. Structure-Activity Relationships of [des-Arg(7)]Dynorphin A Analogues at the κ Opioid Receptor.. J Med Chem. 59(22):10291-10298.

2015

Stevenson GW, Luginbuhl A, Dunbar C, LaVigne J, Dutra J, Atherton P, Bell B, Cone K, Giuvelis D, Polt R et al.. 2015. The mixed-action delta/mu opioid agonist MMP-2200 does not produce conditioned place preference but does maintain drug self-administration in rats, and induces in vitro markers of tolerance and dependence.. Pharmacol Biochem Behav. 132:49-55.